(Bloomberg) Ben Axler’s Spruce Point Capital became one of the most impactful short sellers by spotting problems and digging deeper. The stock market’s closing bell has just rung on the third day of short seller Ben Axler’s campaign against Dexcom Inc. in late March, and things are going pretty much according to plan. That’s to say, things are going terribly for Dexcom.
The Tiny Activist Fund That Reaped 24% Return by Unearthing ‘Cockroaches’
This entry was posted in Syndicated. Bookmark the permalink.
